NEW YORK, NY, BioNeex (www.bioneex.com), the biopharmaceutical industry's first research and development (R&D) business development platform, announced today it has successfully closed its $0.5 million seed round of financing oversubscribed and launched a new $6 million funding round.

Investment in BioNeex's successful seed funding round was led by biopharma industry leaders, including former executives at Pfizer and Amgen.

The BioNeex marketplace connects biotech and biopharma companies, along with venture capital investors, with the most up-to-date drug candidate information directly from drug developers to facilitate biopharma licensing, co-development partnerships and investment.